Results 1 to 10 of about 1,632,982 (236)

Gut microbiota and gut-kidney axis in kidney diseases: therapeutic potential and perspectives of natural products [PDF]

open access: yesFrontiers in Pharmacology
Gut microbiota exert core regulatory effects on systemic metabolic homeostasis and immune balance under physiological and pathological conditions. Marked gut dysbiosis occurs during the progression of chronic kidney disease (CKD), characterized by ...
Qianwei Wang   +6 more
doaj   +3 more sources

The potency of native postbiotics and paraprobiotics in modulating inflammation by affecting the gut–kidney axis [PDF]

open access: yesAnimal Models and Experimental Medicine
Background The gut's impact on kidney health can be observed through its influence on the gut–kidney axis. However, using paraprobiotic and postbiotic agents may improve gut health and kidney function by affecting signaling pathways.
Fatemeh Haririzadeh Jouriani   +6 more
doaj   +3 more sources

The Gut–Kidney Axis in Chronic Kidney Diseases [PDF]

open access: yesDiagnostics
The gut–kidney axis represents the complex interactions between the gut microbiota and kidney, which significantly impact the progression of chronic kidney disease (CKD) and overall patient health.
Kenji Tsuji   +6 more
doaj   +4 more sources

Gut-Kidney Axis: Unraveling the Role of the Microbiome in Chronic Kidney Disease [PDF]

open access: yesBiomedicines
Chronic kidney disease (CKD), which affects over 850 million individuals globally, is increasingly regarded as a systemic condition in which the gut microbiota represents a key pathogenic node.
Mihai Rusu   +4 more
doaj   +3 more sources

The role of mitochondria in the gut-kidney axis: implications for kidney health [PDF]

open access: yesFrontiers in Pharmacology
Mitochondria, multifunctional organelles that regulate cellular energy metabolism and signaling pathways, play a pivotal role in maintaining the physiological functions of the gut and kidneys, as well as influencing the progression of chronic kidney ...
Qin Hu, Hua Jin, Hua Jin, Lan Hu, Xu Li
doaj   +2 more sources

ILC imbalance – a new piece in the gut-kidney axis puzzle [PDF]

open access: yesFrontiers in Immunology
BackgroundThe progression of chronic kidney disease (CKD) is closely linked to gut microbiota dysbiosis and the consequent accumulation of harmful microbial metabolites, forming a vicious cycle called “gut-kidney axis.” However, the specific immune ...
Xinyin Liu   +4 more
doaj   +2 more sources

Precision targeting of gut-kidney axis: mucosal immunomodulation in IgA nephropathy—a perspective [PDF]

open access: yesFrontiers in Medicine
IgA nephropathy (IgAN) is a primary glomerular disease closely linked to mucosal immune dysregulation, involving a complex interplay between intestinal immune homeostasis and renal injury.
Li-hua Sun, Xia-xia Yang
doaj   +2 more sources

Targeting the gut‒kidney axis for lupus nephritis treatment: multimechanism regulatory strategies and evidence from Traditional Chinese medicine [PDF]

open access: yesChinese Medicine
Lupus nephritis (LN) treatment remains challenging because of the limited efficacy and substantial side effects of conventional immunosuppressive therapies.
Qingyun Fang   +15 more
doaj   +2 more sources

A facile polysaccharide hydrogel activates PPARγ via the Gut-Kidney axis to ameliorate chronic kidney disease [PDF]

open access: yesJournal of Nanobiotechnology
Chronic Kidney Disease (CKD) features gut microbiota dysbiosis, systemic inflammation, and impaired barrier function. The formation of such a triad of “microbiota-metabolite-barrier” dysregulation underscores the therapeutic potential of a Gut-Kidney ...
Zhuowen Liang   +11 more
doaj   +2 more sources

Targeting the gut-kidney axis to improve kidney transplantation prognosis: from mechanisms to clinical intervention strategies [PDF]

open access: yesRenal Failure
Kidney transplantation is an important treatment for end-stage renal disease, but lifelong immunosuppression is needed to prevent immune rejection, but the immunosuppressive therapy increases the risk of post-transplant complications.
Huanhuan Cao   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy